Bioinformatics Not Ready for Prime Time?

From larta.org:

"No one doubts the importance of bioinformatics in the drug discovery process, especially as data from R&D grows at exponential levels. But, the growth levels projected for the industry seem overestimated and lofty. The bioinformatics market is yet to mature and create a consistent, predictable, profitable sector for itself in the life science industry. In addition, the industry is one with relatively low barriers to entry and increasing competition from larger established IT companies. Only the fittest companies that address the standardization and integration issues will survive."